Frías SJA

Language: Spanish
References: 20
Page: 19-23
PDF size: 69.72 Kb.

ABSTRACT

Nosocomial infections, is multiplications microorganisms in body, with o without symptoms, adquiried during hospitalized. Etiology and types infections reported is different from hospital-hospital and serviceservice. B. cepacia is novel agents identificed in inmmunocompromissed, childrens, quistic fibrosis. I report 4 firsts cases detected Hospital Central Militar Mexico, adults: 2 urinary tract and 2 traqueal secretions, discussed risks, infections, treatment and evolutions. Literature is revised.

REFERENCES

1. 1.Yabwchi, E., Y. Kosako, H. Oyaizu, Y. Yano y H. Hotta, “Proposal of Burkholderia gen nov and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Pallaroni and Holmes 1981)”, Microbiol. Immunol. 1992; 36: 1251-1275.

2. Gilligan, P. H., “Microbiology of airway disease in patients with cystic fibrosis”, Clin. Microbiol. Rev. 1991; 4: 35-51.

3. Pallent, L., W. B. Hugo, D. J Grant y A. Danier, “Pseudomonas cepacia as contaminant and infective agent”, J. Hosp. Infect. 1983; 4: 9-13.

4. Pegues, D. A., L. A. Carson y L. R Anderson, “Outbreak of Pseudomona cepacia bacteriemia in oncology patients”, Clin. Infect. Dis. 1993; 16: 407-411.

5. O’Neil, K. M., J. H. Herman, J. F. Modlin y E. R. Moxon, “Pseudomonas cepacia: An emerging pathogen in chronic granulomatous disease”, J. Pediatr. 1986; 108: 940-942.

6. Fajardo Olivares, M. F., J. Cordero Carrasco, I. Beteta López, A. B. Escobar Izquierdo y A. Sacristán Enciso, “Faringitis por Burkholderia cepacia. Transmisión de persona a persona”, An. Pediatr. 2004; 60: 581-582.

7. Marioni, G., R. Rinaldi, G. Octaviano, R. Marchese-Ragona, M. Savastano y A. Staffieri, “Cervical necrotizing fasciitis: A novel clinical presentation of Burkholderia cepacia infection”, J. Infection. 2006; 53: 219-222.

8. Fadini, G. P., A. Tiengo y A Avogaro, “First isolation of Burkholderia cepacia from a Deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen”, J. Clin. Microbiol. 2005; 43: 529.

9. Mahenthiralingam, E., T. A. Urban y J. B. Goldberg, “The multifarious, multireplicon Burkholderia cepacia complex”, Nat. Rev. Microbiol. 2005; 3: 144-156.

10. Coenye, T. y J. J. LiPuma, “Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes”, Microbiology. 2003; 149 (Pt 1): 77-88.

11. Bernhardt, S. A., T. Spilker, T. Coffey y J. J. LiPuma, “Burkholderia cepacia complex in Cystic fibrosis: frequency of strain replacement during chronic infection”, Clin. Infect. Dis. 2003; 37: 780-785.

12. Doring, G., S. Jansen et al., “Distribution and transmission of P. aeruginosa and B. cepacia in a Hospital ward”, Pediatr. Pumonol. 1996; 21: 90.

13. Pegues, D. A., D. V. Schidlow et al., “Possible nosocomial transmission of P. cepacia in patients with cystic fibrosis”, Arch. Pediatr. Adolesc. Med. 1994; 149: 805.

14. Allice, T., S. Scutera, M. G. Chirillo y D. Savoia, “Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: Molecular characterization”, J. Infection. 2006; 53:158-165.

15. Coenye, T. y P. Vandamme, “Diversity and significance of Burkholderia species occupying diverse ecological niches”, Environ. Microbiol. 2003; 5: 719-729.

16. Payne, G. W., P. Vandamme, S. H. Morgan, J. J. LiPuma, T. Coenye, A. J. Weightman et al., “Development of a recA gene-based identification approach for the entire Burkholderia genus”, Appl. Environ. Microbiol. 2005; 71: 3917-3927.

17. Greenberg, D. E., B. L. Geller, B. L. Mellbye, L. Ding, P. L. Iversen y S. M. Holland, “Targeted Antisense Molecules and the Burkholderia cepacia Complex: New Drugs for Bad Bugs”, 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IllS., septiembre de 2007: Abs F2-354.

18. Cauthen, B., L. Santiago, F. Alvarado y J. Alonso, “Deaths in a NICU Related to Extrinsically Contaminated Multidose Albuterol Vials”, 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005: Abs K-1369.

19. Díaz Granados, C., A. M. Mantilla, A. Martínez et al., “An outbreak of B. cepacia bacteremia in tertiary care center in Bogota, Colombia”, 44th Infectious Disease Society of America Toronto, Canada, octubre de 2006; Abs 1008.

20. Proyecto de norma oficial mexicana proy-NOM-045-SSA2-2004, para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales, Diario Oficial de la Federación, 19 de agosto de 2004.